Safety Alerts & Recalls
What does this mean?
Ditropan elixir 2.5mg/5ml (also known as oxybutynin) is being recalled as a precautionary measure. Any Ditropan elixir that has been dispensed to patients is unlikely to pose a risk to health.
If you currently take Ditropan elixir please be aware that it may be unavailable for up to 24 months. It is important to contact your doctor who can prescribe an alternative treatment for use while the elixir is unavailable. If you have any concerns about your treatment with Ditropan or other oxybutynin product, then please discuss them with your doctor or other healthcare professional.
If you currently use other forms of oxybutynin (Ditropan, Cystrin, Lyrinel XL tablets or Kentera patches), you should continue to use your medication as normal.
Sanofi-Aventis Recalls All Stock Of Ditropan Elixir
Sanofi-aventis is recalling all stock of Ditropan (oxybutynin) elixir 2.5mg/5ml as a precaution because low levels of non-harmful yeasts have been found in some samples of the elixir during routine testing by the manufacturer. The company has received no complaints linked to this contamination.
Ditropan elixir contains oxybutynin and is used to treat incontinence in adults and bed-wetting in children. Ditropan elixir is likely to be unavailable for up to 24 months as a result of this recall. Brand-name and generic-name oxybutynin products in tablet and patch forms will continue to be available.
For further information please visit: more information here and